Tildrakizumab for the Treatment of Moderate-to-Severe Psoriasis: Results from 52 Weeks Real-Life Retrospective Study

• Main Authors: Ruggiero A (Author), Fabbrocicni G (Author), Cacciapuoti S (Author), Potestio L (Author), Gallo L (Author), Megna M (Author)
• Format: Book
• Published: Dove Medical Press, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Angelo Ruggiero, Gabriella Fabbrocicni, Sara Cacciapuoti, Luca Potestio, Lucia Gallo, Matteo Megna Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence: Angelo Ruggiero, Section of Dermatology, Department of Clinical Medic...